|
1
|
Ditsch N, Wocke A, Untch M, Jackisch C, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer JU, Budach W, Dall P, et al: AGO Recommendations for the diagnosis and treatment of patients with early breast cancer: Update 2022. Breast Care (Basel). 17:403–420. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garufi G, Carbognin L, Schettini F, Seguí E, Di Leone A, Franco A, Paris I, Scambia G, Tortora G and Fabi A: Updated neoadjuvant treatment landscape for early triple negative breast cancer: Immunotherapy, potential predictive biomarkers, and novel agents. Cancers (Basel). 14:40642022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De la Cruz Ku G, Karamchandani M, Chambergo-Michilot D, Narvaez-Rojas AR, Jonczyk M, Príncipe-Meneses FS, Posawatz D, Nardello S and Chatterjee A: Does breast-conserving surgery with radiotherapy have a better survival than mastectomy? A meta-analysis of more than 1,500,000 patients. Ann Surg Oncol. 29:6163–6188. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, Baili P, Rachet B, Gatta G, Hakulinen T, et al: Cancer survival in five continents: A worldwide population-based study (CONCORD). Lancet Oncol. 9:730–756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Santoni M, Rizzo A, Kucharz J, Mollica V, Rosellini M, Marchetti A, Tassinari E, Monteiro FSM, Soares A, Molina-Cerrillo J, et al: Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: The MOUSEION-03 meta-analysis. Cancer Immunol Immunother. 72:1365–1379. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rizzo A, Ricci AD, Lanotte L, Lombardi L, Di Federico A, Brandi G and Gadaleta-Caldarola G: Immune-based combinations for metastatic triple negative breast cancer in clinical trials: Current knowledge and therapeutic prospects. Expert Opin Investig Drugs. 31:557–565. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rizzo A, Cusmai A, Acquafredda S, Rinaldi L and Palmiotti G: Ladiratuzumab vedotin for metastatic triple negative cancer: Preliminary results, key challenges, and clinical potential. Expert Opin Investig Drugs. 31:495–498. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hong R and Xu B: Breast cancer: An up-to-date review and future perspectives. Cancer Commun (Lond). 42:913–936. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eliyatkin N, Yalcin E, Zengel B, Aktas S and Vardar E: Molecular classification of breast carcinoma: From traditional, old-fashioned way to a new age, and a new way. J Breast Health. 11:59–66. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leong AS and Zhuang Z: The changing role of pathology in breast cancer diagnosis and treatment. Pathobiology. 78:99–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hanahan D and Weinberg RA: Hallmarks of Cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li JJ, Tsang JY and Tse GM: Tumor microenvironment in breast cancer-updates on therapeutic implications and pathologic assessment. Cancers (Basel). 13:42332021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hatakeyama M and Nozawa H: Hallmarks of Cancer: After the next generation. Cancer Science. 113:885. 2022.PubMed/NCBI
|
|
14
|
Glabman RA, Choyke PL and Sato N: Cancer-Associated Fibroblasts: Tumorigenicity and targeting for cancer therapy. Cancers (Basel). 14:39062022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo Z, Zhang H, Fu Y, Kuang J, Zhao B, Zhang L, Lin J, Lin S, Wu D and Xie G: Cancer-associated fibroblasts induce growth and radioresistance of breast cancer cells through paracrine IL-6. Cell Death Discov. 9:62023. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gal P, Varinska L, Faber L, Novák Š, Szabo P, Mitrengová P, Mirossay A, Mučaji P and Smetana K: How signaling molecules regulate tumor microenvironment: Parallels to wound repair. Molecules. 22:18182017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giorello MB, Borzone FR, Labovsky V, Piccioni FV and Chasseing NA: Cancer-Associated fibroblasts in the breast tumor microenvironment. J Mammary Gland Biol Neoplasia. 26:135–155. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kolar M, Szabo P, Dvorankova B, Lacina L, Gabius HJ, Strnad H, Sáchová J, Vlček C, Plzák J, Chovanec M, et al: Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: Immunohistochemical and transcriptomic analyses. Biol Cell. 104:738–751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Novak S, Kolar M, Szabo A, Vernerová Z, Lacina L, Strnad H, Šáchová J, Hradilová M, Havránek J, Španko M, et al: Desmoplastic crosstalk in pancreatic ductal adenocarcinoma is reflected by different responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 cell lines to cancer-associated/normal fibroblasts. Cancer Genomics Proteomics. 18:221–243. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Perzel'ova V, Varinska L, Dvorankova B, Szabo P, Spurný P, Valach J, Mojžiš J, André S, Gabius HJ, Smetana K Jr and Gál P: Extracellular matrix of galectin-1-exposed dermal and tumor-associated fibroblasts favors growth of human umbilical vein endothelial cells in vitro: A short report. Anticancer Res. 34:3991–3996. 2014.PubMed/NCBI
|
|
21
|
Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T, et al: A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 20:174–186. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dvorankova B, Szabo P, Lacina L, Kodet O, Matouskova E and Smetana K Jr: Fibroblasts prepared from different types of malignant tumors stimulate expression of luminal marker keratin 8 in the EM-G3 breast cancer cell line. Histochem Cell Biol. 137:679–685. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brozova M, Kleibl Z, Netikova I, Sevcik J, Scholzova E, Brezinova J, Chaloupkova A, Vesely P, Dundr P, Zadinova M, et al: Establishment, growth and in vivo differentiation of a new clonal human cell line, EM-G3, derived from breast cancer progenitors. Breast Cancer Res Treat. 103:247–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao L, Zhao HY and Yan H: Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes. BMC Cancer. 18:6032018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, Ferrari M, Egevad L, Rayford W, Bergerheim U, et al: Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA. 101:811–816. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aure MR, Vitelli V, Jernstrom S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, et al: Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Breast Cancer Res. 19:442017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Strnad H, Lacina L, Kolar M, Cada Z, Vlcek C, Dvoránková B, Betka J, Plzák J, Chovanec M, Sáchová J, et al: Head and neck squamous cancer stromal fibroblasts produce growth factors influencing phenotype of normal human keratinocytes. Histochem Cell Biol. 133:201–211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Szabo P, Kolar M, Dvorankova B, Lacina L, Štork J, Vlček Č, Strnad H, Tvrdek M and Smetana K Jr: Mouse 3T3 fibroblasts under the influence of fibroblasts isolated from stroma of human basal cell carcinoma acquire properties of multipotent stem cells. Biol Cell. 103:233–248. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dvorankova B, Lacina L and Smetana K Jr: Isolation of normal fibroblasts and their cancer-associated counterparts (CAFs) for biomedical research. Methods Mol Biol. 1879:393–406. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Selicharova I, Smutna K, Sanda M, Ubik K, Matousková E, Bursíková E, Brozová M, Vydra J and Jirácek J: 2-DE analysis of a new human cell line EM-G3 derived from breast cancer progenitor cells and comparison with normal mammary epithelial cells. Proteomics. 7:1549–1559. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mladkova J, Sanda M, Matouskova E and Selicharova I: Phenotyping breast cancer cell lines EM-G3, HCC1937, MCF7 and MDA-MB-231 using 2-D electrophoresis and affinity chromatography for glutathione-binding proteins. BMC Cancer. 10:4492010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rheinwald JG and Green H: Serial cultivation of strains of human epidermal keratinocytes-formation of keratinizing colonies from single cells. Cell. 6:331–344. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu M, Zhang T, Xia R, Wei Y and Wei X: Targeting the tumor stroma for cancer therapy. Mol Cancer. 21:2082022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W and Smyth GK: limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML, Kropiwnicki E, Jagodnik KM, et al: Gene set knowledge discovery with enrichr. Curr Protoc. 1:e902021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Athar A, Fullgrabe A, George N, Iqbal H, Huerta L, Ali A, Snow C, Fonseca NA, Petryszak R, Papatheodorou I, et al: ArrayExpress update-from bulk to single-cell expression data. Nucleic Acids Res. 47((D1)): D711–D715. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang YT, Kuo LT, Weng HH, Hsu CM, Tsai MS, Chang GH, Lee YC, Huang EI and Tsai YT: Systemic Immun e-inflammation index as a predictor for head and neck cancer prognosis: A meta-analysis. Front Oncol. 12:8995182022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Setiawan T, Sari IN, Wijaya YT, Julianto NM, Muhammad JA, Lee H, Chae JH and Kwon HY: Cancer cachexia: Molecular mechanisms and treatment strategies. J Hematol Oncol. 16:542023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hanley CJ and Thomas GJ: Targeting cancer associated fibroblasts to enhance immunotherapy: Emerging strategies and future perspectives. Oncotarget. 12:1427–1433. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L, Gudjonsson T, Rank F, LaBarge MA, Bissell MJ and Petersen OW: Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol. 177:87–101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Romano V, Ruocco MR, Carotenuto P, Barbato A, Venuta A, Acampora V, De Lella S, Vigliar E, Iaccarino A, Troncone G, et al: Generation and Characterization of a tumor stromal microenvironment and analysis of its interplay with breast cancer cells: An in vitro model to study breast cancer-associated fibroblast inactivation. Int J Mol Sci. 23:68752022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ao Z, Shah SH, Machlin LM, Parajuli R, Miller PC, Rawal S, Williams AJ, Cote RJ, Lippman ME, Datar RH and El-Ashry D: Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer. Cancer Res. 75:4681–4687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Iyer SV, Dange PP, Alam H, Sawant SS, Ingle AD, Borges AM, Shirsat NV, Dalal SN and Vaidya MM: Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines. PLoS One. 8:e535322013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hanley CJ, Henriet E, Sirka OK, Thomas GJ and Ewald AJ: Tumor-Resident Stromal cells promote breast cancer invasion through regulation of the basal phenotype. Mol Cancer Res. 18:1615–1622. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cheung KJ, Gabrielson E, Werb Z and Ewald AJ: Collective invasion in breast cancer requires a conserved basal epithelial program. Cell. 155:1639–1651. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cserni G, Francz M, Jaray B, Kálmán E, Kovács I, Krenács T, Tóth E, Udvarhelyi N, Vass L, Vörös A, et al: Pathological diagnosis, work-up and reporting of breast cancer 1st central-eastern european professional consensus statement on breast cancer. Pathol Oncol Res. 28:16103732022. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang X, Ji S, Ma Y, Xing X, Zhou Y, Xu X, Song J, Wang S, Jiang W, Wang X, et al: Vimentin plays an important role in the promotion of breast cancer cell migration and invasion by leucine aminopeptidase 3. Cytotechnology. 72:639–647. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen MH, Yip GW, Tse GM, Moriya T, Lui PC, Zin ML, Bay BH and Tan PH: Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters. Mod Pathol. 21:1183–1191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Yamashita N, Tokunaga E, Kitao H, Hisamatsu Y, Taketani K, Akiyoshi S, Okada S, Aishima S, Morita M and Maehara Y: Vimentin as a poor prognostic factor for triple-negative breast cancer. J Cancer Res Clin Oncol. 139:739–746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang Z, Fang T and Lv Y: Prognostic and clinicopathological value of Slug protein expression in breast cancer: A systematic review and meta-analysis. World J Surg Oncol. 20:3612022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Soini Y, Tuhkanen H, Sironen R, Virtanen I, Kataja V, Auvinen P, Mannermaa A and Kosma VM: Transcription factors zeb1, twist and snai1 in breast carcinoma. BMC Cancer. 11:732011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Horne HN, Oh H, Sherman ME, Palakal M, Hewitt SM, Schmidt MK, Milne RL, Hardisson D, Benitez J, Blomqvist C, et al: E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. Sci Rep. 8:65742018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hazan RB, Phillips GR, Qiao RF, Norton L and Aaronson SA: Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 148:779–790. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Brock T, Boudriot E, Klawitter A, Großer M, Nguyen TTP, Giebe S, Klapproth E, Temme A, El-Armouche A and Breier G: The Influence of VE-Cadherin on adhesion and incorporation of breast cancer cells into vascular endothelium. Int J Mol Sci. 22:60492021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, Lameiras S, Albergante L, Bonneau C, Guyard A, et al: Single-Cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 10:1330–1351. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, et al: Prognosis of metastatic breast cancer: Are there differences between patients with de novo and recurrent metastatic breast cancer? Br J Cancer. 112:1445–1451. 2015. View Article : Google Scholar : PubMed/NCBI
|
